Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
Clinical trial NCT05151588 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05151588
- Sponsor
- Dr. Victor H.F. Lee
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.